BENEFICIAL HEMODYNAMIC-RESPONSE TO CHRONIC PRAZOSIN THERAPY IN CONGESTIVE HEART-FAILURE

被引:40
作者
FELDMAN, RC [1 ]
BALL, RM [1 ]
WINCHESTER, MA [1 ]
JAILLON, P [1 ]
KATES, RE [1 ]
HARRISON, DC [1 ]
机构
[1] STANFORD UNIV, MED CTR, SCH MED, DIV CARDIOL, STANFORD, CA 94305 USA
关键词
D O I
10.1016/0002-8703(81)90218-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:534 / 540
页数:7
相关论文
共 14 条
[1]   ATTENUATION OF PRAZOSIN EFFECT ON CARDIAC-OUTPUT IN CHRONIC HEART-FAILURE [J].
ARNOLD, SB ;
WILLIAMS, RL ;
PORTS, TA ;
BAUGHMAN, RA ;
BENET, LZ ;
PARMLEY, WW ;
CHATTERJEE, K .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (03) :345-349
[2]   EFFECT OF PRAZOSIN VS PLACEBO ON CHRONIC LEFT-VENTRICULAR HEART-FAILURE [J].
ARONOW, WS ;
LURIE, M ;
TURBOW, M ;
WHITTAKER, K ;
VANCAMP, S ;
HUGHES, D .
CIRCULATION, 1979, 59 (02) :344-350
[3]   EFFICACY OF AMBULATORY SYSTEMIC VASODILATOR THERAPY WITH ORAL PRAZOSIN IN CHRONIC REFRACTORY HEART-FAILURE - CONCOMITANT RELIEF OF PULMONARY CONGESTION AND ELEVATION OF PUMP OUTPUT DEMONSTRATED BY IMPROVEMENTS IN SYMPTOMATOLOGY, EXERCISE TOLERANCE, HEMODYNAMICS AND ECHOCARDIOGRAPHY [J].
AWAN, NA ;
MILLER, RR ;
DEMARIA, AN ;
MAXWELL, KS ;
NEUMANN, A ;
MASON, DT .
CIRCULATION, 1977, 56 (03) :346-354
[4]   DEVELOPMENT OF SYSTEMIC VASODILATOR TOLERANCE TO PRAZOSIN WITH CHRONIC USE OF AGENT IN AMBULATORY THERAPY OF SEVERE CONGESTIVE HEART-FAILURE [J].
AWAN, NA ;
MILLER, RR ;
MAXWELL, KS ;
MASON, DT .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (02) :367-367
[5]   CLINICAL PHARMACOLOGY AND THERAPEUTIC APPLICATION OF PRAZOSIN IN ACUTE AND CHRONIC REFRACTORY CONGESTIVE HEART-FAILURE - BALANCED SYSTEMIC VENOUS AND ARTERIAL DILATION IMPROVING PULMONARY CONGESTION AND CARDIAC-OUTPUT [J].
AWAN, NA ;
MILLER, RR ;
MILLER, MP ;
SPECHT, K ;
VERA, Z ;
MASON, DT .
AMERICAN JOURNAL OF MEDICINE, 1978, 65 (01) :146-154
[6]   LONG-TERM THERAPY OF HEART-FAILURE WITH PRAZOSIN - RANDOMIZED DOUBLE-BLIND TRIAL [J].
COLUCCI, WS ;
WYNNE, J ;
HOLMAN, BL ;
BRAUNWALD, E .
AMERICAN JOURNAL OF CARDIOLOGY, 1980, 45 (02) :337-344
[7]   DEVELOPMENT OF PHARMACODYNAMIC TOLERANCE TO PRAZOSIN IN CONGESTIVE HEART-FAILURE [J].
DESCH, CE ;
MAGORIEN, RD ;
TRIFFON, DW ;
BLANFORD, MF ;
UNVERFERTH, DV ;
LEIER, CV .
AMERICAN JOURNAL OF CARDIOLOGY, 1979, 44 (06) :1178-1182
[8]   MARKED EARLY ATTENUATION OF HEMODYNAMIC-EFFECTS OF ORAL PRAZOSIN THERAPY IN CHRONIC CONGESTIVE HEART-FAILURE [J].
ELKAYAM, U ;
LEJEMTEL, TH ;
MATHUR, M ;
RIBNER, HS ;
FRISHMAN, WH ;
STROM, J ;
SONNENBLICK, EH .
AMERICAN JOURNAL OF CARDIOLOGY, 1979, 44 (03) :540-545
[9]   IMPROVED EXERCISE EJECTION FRACTION WITH LONG-TERM PRAZOSIN THERAPY IN PATIENTS WITH HEART-FAILURE [J].
GOLDMAN, SA ;
JOHNSON, LL ;
ESCALA, E ;
CANNON, PJ ;
WEISS, MB .
AMERICAN JOURNAL OF MEDICINE, 1980, 68 (01) :36-42
[10]   SUSTAINED REDUCTION OF CARDIAC IMPEDANCE AND PRELOAD IN CONGESTIVE HEART-FAILURE WITH ANTIHYPERTENSIVE VASODILATOR PRAZOSIN [J].
MILLER, RR ;
AWAN, NA ;
MAXWELL, KS ;
MASON, DT .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (06) :303-307